* Sanofi and Regeneron say Praluent shows positive
investigational data in phase 3 trial
Further company coverage:
(Reporting by Laurence Frost)
The post BRIEF-Sanofi and Regeneron say Praluent shows positive phase 3 trial data appeared first on NASDAQ.